The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 7639-7648
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanchez-Lockhart, M.
Right arrow Articles by Miller, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanchez-Lockhart, M.
Right arrow Articles by Miller, J.

Signals and Sequences That Control CD28 Localization to the Central Region of the Immunological Synapse1

Mariano Sanchez-Lockhart*, Beth Graf* and Jim Miller2,*,{dagger}

* The David H. Smith Center for Vaccine Biology and Immunology and the {dagger} Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642

During T cell interaction with APC, CD28 is recruited to the central region (cSMAC) of the immunological synapse. CD28-mediated signaling through PI3K results in the recruitment of protein kinase C-{theta} (PKC{theta}) to the cSMAC, activation of NF-{kappa}B, and up-regulation of IL-2 transcription. However, the mechanism that mediates CD28 localization to the cSMAC and the functional consequences of CD28 localization to the cSMAC are not understood. In this report, we show that CD28 recruitment and persistence at the immunological synapse requires TCR signals and CD80 engagement. Addition of mAb to either MHC class II or CD80 results in the rapid displacement of CD28 from the immunological synapse. Ligand binding is not sufficient for CD28 localization to the immunological synapse, as truncation of the cytosolic tail of CD28 disrupts synapse localization without effecting the ability of CD28 to bind CD80. Furthermore, a single point mutation in the CD28 cytosolic tail (tyrosine 188) interferes with the ability of CD28 to preferentially accumulate at the cSMAC. PKC{theta} distribution at the immunological synapse mirrors the distribution of tyrosine 188-mutated CD28, indicating that CD28 drives the localization of PKC{theta} even when CD28 is not localized to the cSMAC. Mutation of tyrosine 188 also results in diminished activation of NF-{kappa}B, suggesting that CD28-mediated localization of PKC{theta} to the cSMAC is important for efficient signal transduction. These data reinforce the importance of the interplay of signals between TCR and CD28 and suggest that CD28 signaling through PCK{theta} may be mediated through localization to the cSMAC region of the immunological synapse.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grant R01-AI063418 from the National Institutes of Health (to J. M.). M.S.L. was supported by National Institutes of Health Training Grant T32-AI007169.

2 Address correspondence and reprint requests to Dr. Jim Miller, Center for Vaccine Biology and Immunology, University of Rochester, Box 609, 601 Elmwood Avenue, Rochester, NY 14642-8609. E-mail address: jim_miller{at}urmc.rochester.edu

3 Abbreviations used in this paper: SH, Src homology domain; SMAC, supramolecular activation cluster; cSMAC, central SMAC; pSMAC, peripheral SMAC; PKC{theta}, protein kinase C-{theta}; IS, immunological synapse; WT, wild type; IRES, internal ribosomal entry site; CT, cytosolic tail; DIC, differential interference contrast; CFP, cyan fluorescent protein.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.